Recruiting Duvelisib and Venetoclax in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (PTCL) NCT06810778 Conditions Cutaneous T-Cell Lymphoma Refractory, Disease Attributes, Hematologic Diseases, +16 more Locations David Geffen School of Medicine at the University of California at Los Angeles — Los Angeles, California, United States View Trial Details
Recruiting Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL. NCT04771572 Conditions Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Blood Protein Disorders, +48 more Locations University of Chicago — Chicago, Illinois, United States Dana Farber Cancer Institute — Boston, Massachusetts, United States University of North Carolina — Chapel Hill, North Carolina, United States Cincinnati Children's Hospital Medical Center — Cincinnati, Ohio, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Combined Immunochemotherapy in Patients With T-Prolymphocytic Leukemia (T-PLL) NCT01186640 Conditions Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more Locations University Hospital Cologne — Cologne, Germany View Trial Details
Completed A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) NCT00749502 Conditions Adnexal Diseases, Chronic Disease, Chronic Lymphocytic Leukemia, +38 more Locations Not specified View Trial Details
